Transparency data

Voluntary scheme aggregate net sales and payment information: May 2026

Information on how the 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG) is controlling spend on branded medicines in the NHS.

• From: Department of Health and Social Care
• Published: 17 June 2026

Documents

Aggregate net sales and payment information: May 2026

HTML

Details

This publication sets out the NHS’s quarterly aggregate net sales and payment information on pharmaceuticals for May 2026.

The 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG) is an agreement between the Department of Health and Social Care, NHS England and the Association of the British Pharmaceutical Industry that aims to:

• promote better patient outcomes and a healthier population
• support UK economic growth
• contribute to a financially sustainable NHS

Published 17 June 2026